title: Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting.
authors.affiliation: London School of Hygiene and Tropical Medicine, London, UK. clare.vanhalsema@lshtm.ac.uk
authors.forename: Clare L
authors.initials: CL
authors.lastname: van Halsema
authors.forename: Katherine L
authors.initials: KL
authors.lastname: Fielding
authors.forename: Violet N
authors.initials: VN
authors.lastname: Chihota
authors.forename: Elizabeth C
authors.initials: EC
authors.lastname: Russell
authors.forename: James J C
authors.initials: JJ
authors.lastname: Lewis
authors.forename: Gavin J
authors.initials: GJ
authors.lastname: Churchyard
authors.forename: Alison D
authors.initials: AD
authors.lastname: Grant
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000453:epidemiology*; D015497:HIV-1; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D008297:Male; D015995:Prevalence; D013019:South Africa / Q000453:epidemiology; D016896:Treatment Outcome; D014376:Tuberculosis / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid